92 related articles for article (PubMed ID: 22098593)
1. Comparison of manual and digital microvascular density counting of RECK expression in glioma.
Rahmah NN; Sakai K; Li Y; Sano K; Hongo K
Neuropathology; 2012 Jun; 32(3):245-51. PubMed ID: 22098593
[TBL] [Abstract][Full Text] [Related]
2. The potential of RECK inducers as antitumor agents for glioma.
Chen Y; Tseng SH
Anticancer Res; 2012 Jul; 32(7):2991-8. PubMed ID: 22753763
[TBL] [Abstract][Full Text] [Related]
3. Expression of RECK in endothelial cells of glioma: comparison with CD34 and VEGF expressions.
Rahmah NN; Sakai K; Sano K; Hongo K
J Neurooncol; 2012 May; 107(3):559-64. PubMed ID: 22183444
[TBL] [Abstract][Full Text] [Related]
4. Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
Liu X; Wang W; Chen J; Chen C; Zhou J; Cao L
ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):16-21. PubMed ID: 22178867
[TBL] [Abstract][Full Text] [Related]
5. Morphometric study of nuclei and microvessels in gliomas and its correlation with grades.
Boruah D; Deb P; Srinivas V; Mani NS
Microvasc Res; 2014 May; 93():52-61. PubMed ID: 24657905
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell counting using an image analysis program for MIB-1 immunohistochemistry.
Ide M; Jimbo M; Yamamoto M; Kubo O
Neurol Med Chir (Tokyo); 1997 Feb; 37(2):158-62. PubMed ID: 9059038
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Hasegawa S; Otake Y; Morioka Y; Takahashi C; Noda M; Ito H; Wada H; Tanaka F
Ann Surg Oncol; 2005 Oct; 12(10):817-24. PubMed ID: 16132376
[TBL] [Abstract][Full Text] [Related]
8. Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas.
Jain R; Narang J; Gutierrez J; Schultz LR; Scarpace L; Rosenblum M; Mikkelsen T; Rock JP
Acad Radiol; 2011 Aug; 18(8):955-62. PubMed ID: 21718954
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of MIB-1 staining indices of gliomas measured by NIH Image analysis program and conventional manual cell counting method.
Amin MR; Kurosaki M; Watanabe T; Tanaka S; Hori T
Neurol Res; 2000 Jul; 22(5):495-500. PubMed ID: 10935223
[TBL] [Abstract][Full Text] [Related]
10. Reduced Expression of RECK Protein May Help Differentiate Cutaneous Malignant Melanoma from Melanocytic Nevus.
Zhang L; Xie Q; Shan SJ; Tabor MK; Junkins-Hopkins JM
Anticancer Res; 2015 Jun; 35(6):3185-91. PubMed ID: 26026078
[TBL] [Abstract][Full Text] [Related]
11. Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences?
Malmer B; Brännström T; Andersson U; Bergh K; Grönberg H; Henriksson R
Anticancer Res; 2002; 22(6C):3949-54. PubMed ID: 12553017
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell density in donor corneas: a comparison of automatic software programs with manual counting.
Hirneiss C; Schumann RG; Grüterich M; Welge-Luessen UC; Kampik A; Neubauer AS
Cornea; 2007 Jan; 26(1):80-3. PubMed ID: 17198018
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in malignant gliomas.
Plate KH; Risau W
Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
[TBL] [Abstract][Full Text] [Related]
14. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Song SY; Son HJ; Nam E; Rhee JC; Park C
Eur J Cancer; 2006 Jan; 42(1):101-8. PubMed ID: 16324834
[TBL] [Abstract][Full Text] [Related]
15. [Expression of MT1-MMP and RECK protein in human gastric carcinoma].
Shen B; Zheng MQ; Xu XY; Mo FG; Zhang T; Feng JF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):364-7. PubMed ID: 22338226
[TBL] [Abstract][Full Text] [Related]
16. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
Span PN; Sweep CG; Manders P; Beex LV; Leppert D; Lindberg RL
Cancer; 2003 Jun; 97(11):2710-5. PubMed ID: 12767082
[TBL] [Abstract][Full Text] [Related]
19. Multi-photon excitation fluorescence microscopy of brain-tumour tissue and analysis of cell density.
Kantelhardt SR; Leppert J; Kantelhardt JW; Reusche E; Hüttmann G; Giese A
Acta Neurochir (Wien); 2009 Mar; 151(3):253-62; discussion 262. PubMed ID: 19238321
[TBL] [Abstract][Full Text] [Related]
20. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]